The MaGiCAD study is a large study, with input from many different
people and institutions. It's base is at Papworth
Hospital NHS Trust, in Cambridgeshire, and it is run in conjunction
with scientists from the University of
Cambridge and a Commercial Sponsor, TCP Innovations.
A brief introduction into the staff involved with MaGiCAD is given
below:
Management Committee
Dr.
David Mosedale (chair)
Dr. Peter Schofield (Lead Clinician)
Dr. Sarah Clarke
Dr. Hester Goddard
Dr. David Grainger
Clinical Research Associates
Mrs.
Sarah Hayns (study co-ordinator)
Dr.
Claire Nugent
Mrs. Caryl Barnard
Ms. Annik Panicker
Management Committee
The Management
Committee is responsible for the overall running of the MaGiCAD study,
in accordance with the MaGiCAD Constitution.
Dr.
David Mosedale |
|
David
Mosedale graduated from Girton College, Cambridge University
in 1993 and completed his Ph.D. degree, under the supervision
of Prof. Jim Metcalfe and Dr. David Grainger, in 1996.
He is currently employed as a Clinical Scientist at Papworth
Hospital, but remains an associate scientist in the Inflammation
Research and Therapy group in the Department of Medicine,
University of Cambridge where he worked from 1996 to
2003. Dr. Mosedale's research interests include developing
new antibody-based detection methods (he pioneered the
application of quantitative immunofluoresence technology)
and more recently in the application of these methods
to the epidemiology of heart disease. |
top
|
Dr.
Peter Schofield |
|
Peter
Schofield is a consultant cardiologist at Papworth Hospital.
In addition to his clinical duties, he is also head of
the Cardiac Studies Unit and is responsible for a considerable
amount of Research done at Papworth Hospital. His interests
range from clinical research, evaluating new therapeutic
approaches to the treatment of coronary heart disease
(both surgical and medical) through to basic laboratory-based
research aimed at better understanding the pathophysiological
processes which accompany development of heart disease. |
top
|
top
|
Dr.
Hester Goddard |
|
At
the start of her career Dr Hester Goddard pursued an
interest in the early development of mammalian embryos
(both mice and men!). She was awarded a PhD for her research
at the MRC labs in Mill Hill and then came to Cambridge
University where she worked with other scientists trying
to answer the question how one single cell becomes an
embryo. During this period she supervised research students
and taught undergraduates at Cambridge and other universities
in Europe and USA. She then developed her interest in
communicating science by working as a commissioning editor
for a number of publishers, teaching secondary and sixth
form science and writing for children. She has now returned
to a research environment as a Research Officer in the
R&D Unit at Papworth Hospital. Her role involves
assisting staff in designing and managing their clinical
studies so that they get reliable answers to their research
questions! |
top
|
Dr.
David Grainger |
|
David
Grainger graduated from Magdalene College, Cambridge
University in 1989 and went on to study for a Ph.D. under
the supervision of Profs. Jim Metcalfe and Peter Weissberg
in the Department of Biochemistry, University of Cambridge.
Since 1994, he has been a Royal Society University Research
Fellow, currently based in the Department of Medicine,
University of Cambridge, located at Addenbrooke's Hospital.
He is the principal investigator of the Inflammation
Research and Therapy group, which primarily researches
into the role of inflammation in cardiovascular disease,
with particular focus on cytokines and signalling molecules. |
top
|
Clinical Research Associates
The Clinical Research Associates are responsible for the day-to-day
running of MaGiCAD. They select the patients to approach from the daily
list, conduct the patient questionnaires and prepare blood samples.
Ms.
Sarah Hayns |
|
Sarah
Hayns graduated from the University of Sussex in 1993
with a first class honours degree in biology (specialising
in molecular biology). She subsequently spent two years
in a molecular biology research lab at the MRC Cell Mutation
Unit, University of Sussex. Sarah has since worked in
various clinical roles including veterinary nursing at
a practice in Portsmouth and a vascular technician position
at the Queen Alexandra Hospital, Portsmouth. The latter
involved performing Doppler scans on patients with peripheral
vascular disease. She remains particularly interested
in vascular disease and is currently employed as a clinical
research assistant at Papworth
Hospital. Sarah works 30 hours/week and is
currently the Study Co-ordinator for MaGiCAD. |
top
|
Dr.
Claire Nugent |
|
Claire
Nugent graduated from Emmanuel College, Cambridge University
in 1996 and went on to study for a PhD. in Prof. Stephen
O'Rahilly's Insulin Signalling Group in the Department
of Clinical Biochemistry, University of Cambridge. Following
on from this, she spent a year working as a Development
Editor in the Biological Sciences Group of Cambridge
University Press. She has now moved back into research
and is currently employed as a clinical research assistant
in the Cardiac Studies Unit at Papworth Hospital working
on the MaGiCAD study. Claire has recently gone
on maternity leave and we wish both her and her husband
David best wishes with the next few months. |
top
|
Mrs.
Caryl Barnard |
|
Caryl
Barnard graduated as a biomedical scientist in Australia
and has worked in hospital and university laboratories
doing both routine clinical and research projects, with
a particular interest in immunology and tissue culture.
Since coming to the UK in 1988, this interest has broadened
to fertility monitoring and insulin studies. Caryl has
taken time-out from science to work as a conference co-ordinator
but is now enjoying being a clinical research assistant
with the MaGiCAD study based in the Cardiac Studies Unit
at Papworth Hospital. |
top
|
Ms.
Annik Panicker |
|
Annik
Panicker completed her honours degree at the University
of Western Australia majoring in biochemistry and molecular
biology. She came to the UK in 1997 and worked in the
pharmaceutical industry where she was involved in the
development of cell-based high throughput screens for
drug discovery. Her most recent research was in the field
of cardiac ion channels. Annik's main responsibility
is to act as Study Co-ordinator for the Longitudinal
Study under the direction of David Mosedale, but she
is also a part-time member of the MaGiCAD study team. |
top
|
|